Credit Suisse analysts cut their rating on Sun Pharma stock to 'neutral' from 'outperform
The rap from both the US and UK drug regulators, including the latest one from the latter, has hit the scrip.
Calling for 'equal recognition of vaccines', COVAX on Thursday urged all governments to recognise as 'fully vaccinated' those people who have received COVID-19 vaccines deemed safe by World Health Organisation, saying any move that restricts travel of people based on the vaccines they have received is 'counter-effective, both in spirit and outcome'.
The company has not yet revealed details about the unexplained illness but has stopped trials while doctors find out if the illness was caused due to the vaccine or was a coincidence.
'Safety is my first priority.' 'I need to ensure that any drug or vaccine that our citizens get is first safe.'
The recall is the latest in a series of problems to hit Ranbaxy, which has had all its India factories stopped from sending drugs and ingredients to the United States.
The US laws authorise the drug and health watchdog to assess and collect user fees for certain applications and supplements for human generic drug products
'You ain't seen anything yet,' EAM Jaishankar says about the India-US relationship.
The test named the "SARS-CoV-2 DETECTR" is easy to implement and to interpret, and requires no specialised equipment, said researchers from the University of California, San Francisco in the US.
The merger has fortified Sun Pharma's position.
With this allocation of portfolios, the Sharad Pawar-led NCP has got most of the 'plum' ministries.
Nestl India is preparing a blueprint for a possible relaunch.
'In the likelihood that Omicron is circulating, you have a much greater chance of getting infected now, than you did during the Age of Delta.'
At least 85 people have died of coronavirus with the confirmed cases crossing 4,500 in the US.
Some Indian generic drugmakers are, however, uncertain about the pace of approvals in the near future.
Slapped with Rs 242-crore fine by US authorities for rule violations at Toansa unit, say sources; 2nd such hefty rap in the recent past from US regulators for bending rules.
Analysts are eyeing bigger launches that will positively impact company's fortunes.
The BSE Midcap also cut all its intraday gains to shed 0.3% at close
At $37 per dose, the Pfizer vaccine is much more expensive compared to $3 per dose for the Covishield.
A key lesson for the pharmaceutical sector in this case is to not downplay the significant impact that regulatory non-compliance can have on operations.
The vaccine arrives at a critical moment for the US. Hospitalisations due to COVID-19 hit record highs for the seventh day in a row on Saturday.
OBC leader Dharam Singh Saini on Thursday became the third minister to resign from the Uttar Pradesh cabinet this week, giving yet another jolt to the ruling Bharatiya Janata Party in the run-up to the assembly polls.
Altaf Ahmed Lal, country head of the US Food and Drug Administration (US FDA) in India, has quit and so have a few other key officials at the American drug regulator's India office.
Many countries found Maggi noodles to be safe for consumption.
Trump also raised the possibility of using light to combat the deadly viral infection.
These vaccines have not yet been approved by the World Health Organization
The US Food and Drug Administration said on Sunday that over 70,000 patients in the country had been treated with convalescent plasma, which is made using the blood of people who have recovered from coronavirus infections.
The names of two Indian-Americans -- Seema Verma and Bobby Jindal -- have emerged as possible candidates.
Last month, the US Food and Drugs Administration had placed Wockhardt's facilities in Waluj near Aurangabad on import alert, barring supply of various products from these facilities to the US.
The news that exports to the US will not restart before next year as well as the September quarter performance are sentiment dampeners.
Low growth visibility and trouble with regulators have resulted in lack of interest from investors
"Due to scheduling reasons, it is inconvenient for China to attend the meeting," Chinese Foreign Ministry spokesman Wang Wenbin told mediapersons.
.jpg)
To focus on molecules at advanced stage of development; move to impact 200 scientists.
The company has received a communication from the Medicines and Healthcare Products Regulatory Agency, United Kingdom, whereby the agency has decided to withdraw the previously issued GMP Certificate to the company's manufacturing facility situated at Kadaiya, Nani Daman, Wockhardt said in a filing to the Bombay Stock Exchange.
Wockhardt MD Murtaza Khorakiwala said his firm had responded to the FDA's observations but declined to give details.
The Indian Pharmaceutical Alliance has approached regulator for a dialogue to understand the concern raised by it
This is not just a Ranbaxy or Wockhardt problem, says K Satish Reddy
In 2014, Sun Pharma agreed to buy Ranbaxy -- which was then controlled by Daiichi.
Test reports from UP food regulator started the controversy.
The company buys distressed assets across the globe and turns them around to not only add to its books but also its product pipeline and regions.
